| Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration JP Vandenbroucke, E Elm, DG Altman, PC Gøtzsche, CD Mulrow, ... Annals of internal medicine 147 (8), W-163-W-194, 2007 | 10357 | 2007 |
| A modified poisson regression approach to prospective studies with binary data G Zou American journal of epidemiology 159 (7), 702-706, 2004 | 8800 | 2004 |
| STrengthening the REporting of Genetic Association Studies (STREGA)—an extension of the STROBE statement J Little, JPT Higgins, JPA Ioannidis, D Moher, F Gagnon, E Von Elm, ... Genetic Epidemiology: The Official Publication of the International Genetic …, 2009 | 1486 | 2009 |
| Toward using confidence intervals to compare correlations. GY Zou Psychological methods 12 (4), 399, 2007 | 785 | 2007 |
| C-reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and … MH Mosli, G Zou, SK Garg, SG Feagan, JK MacDonald, N Chande, ... Official journal of the American College of Gastroenterology| ACG 110 (6 …, 2015 | 716 | 2015 |
| Extension of the modified Poisson regression model to prospective studies with correlated binary data GY Zou, A Donner Statistical methods in medical research 22 (6), 661-670, 2013 | 675 | 2013 |
| Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial R Khanna, B Bressler, BG Levesque, G Zou, LW Stitt, GR Greenberg, ... The Lancet 386 (10006), 1825-1834, 2015 | 497 | 2015 |
| Sample size formulas for estimating intraclass correlation coefficients with precision and assurance GY Zou Statistics in medicine 31 (29), 3972-3981, 2012 | 456 | 2012 |
| A simplified approach to the treatment of uncomplicated hypertension: a cluster randomized, controlled trial RD Feldman, GY Zou, MK Vandervoort, CJ Wong, SAE Nelson, ... hypertension 53 (4), 646-653, 2009 | 420 | 2009 |
| Methotrexate in combination with infliximab is no more effective than infliximab alone in patients with Crohn's disease BG Feagan, JWD McDonald, R Panaccione, RA Enns, CN Bernstein, ... Gastroenterology 146 (3), 681-688. e1, 2014 | 396 | 2014 |
| Omega-3 free fatty acids for the maintenance of remission in Crohn disease: the EPIC Randomized Controlled Trials BG Feagan, WJ Sandborn, U Mittmann, S Bar-Meir, G D’Haens, ... Jama 299 (14), 1690-1697, 2008 | 359 | 2008 |
| Development and validation of a histological index for UC MH Mosli, BG Feagan, G Zou, WJ Sandborn, G D'Haens, R Khanna, ... Gut 66 (1), 50-58, 2017 | 352 | 2017 |
| The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease NV Casteele, R Khanna, BG Levesque, L Stitt, GY Zou, S Singh, ... Gut 64 (10), 1539-1545, 2015 | 337 | 2015 |
| On the estimation of additive interaction by use of the four-by-two table and beyond GY Zou American journal of epidemiology 168 (2), 212-224, 2008 | 291 | 2008 |
| Construction of confidence limits about effect measures: a general approach GY Zou, A Donner Statistics in medicine 27 (10), 1693-1702, 2008 | 269 | 2008 |
| Endoscopic scoring indices for evaluation of disease activity in ulcerative colitis NM Vashist, M Samaan, MH Mosli, CE Parker, JK MacDonald, SA Nelson, ... Cochrane Database of Systematic Reviews, 2018 | 251 | 2018 |
| Confidence interval estimation for the Bland–Altman limits of agreement with multiple observations per individual GY Zou Statistical methods in medical research 22 (6), 630-642, 2013 | 221 | 2013 |
| The role of centralized reading of endoscopy in a randomized controlled trial of mesalamine for ulcerative colitis BG Feagan, WJ Sandborn, G D'Haens, S Pola, JWD McDonald, ... Gastroenterology 145 (1), 149-157. e2, 2013 | 220 | 2013 |
| Clinical and pharmacogenetic predictors of circulating atorvastatin and rosuvastatin concentrations in routine clinical care MK DeGorter, RG Tirona, UI Schwarz, YH Choi, GK Dresser, N Suskin, ... Circulation: Cardiovascular Genetics 6 (4), 400-408, 2013 | 213 | 2013 |
| A retrospective analysis: the development of patient reported outcome measures for the assessment of Crohn's disease activity R Khanna, G Zou, G D'haens, BG Feagan, WJ Sandborn, MK Vandervoort, ... Alimentary pharmacology & therapeutics 41 (1), 77-86, 2015 | 209 | 2015 |
